Eisai R&D Management Co., Ltd., a subsidiary of Eisai Co., Ltd., is a company headquartered in Bunkyo, Japan. The firm engages in research and development of pharmaceuticals.

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

Je Il Pharm Co., Ltd. is a private company headquartered in Daegu, the South Korea, that manufactures and sells pharmaceutical products.

S.Biomedics Co. Ltd. operates as a biotechnology company. It engages in the research and development of cell therapies for regenerative biomedicine. The company was founded in August 2003 and is headquartered in Seoul, South Korea.

Wuhan Ruijian Pharmaceutical Technology Co., Ltd. is a Chinese company located in Wuhan that offers human neural stem cells that help in pharmacology and toxicology testing and new drug development. It was founded in 2017 by Jun Wei, who has been the CEO since that date.

Shandong Qilu Stem Cells Engineering Co. Ltd. operates a cord blood bank. The firm offers stem cell clinical research and technology development, and umbilical cord blood stem cell preservation services. The company was founded in July 2004 and is headquartered in Jinan, China.

Longma (Shanghai) Pharmaceutical Research and Development Co., Ltd., established on 2020-07-10, Business scope includes general items:Pharmaceutical research and development,R&D of cosmetics,wholesale;Biological Technology(human stem cells,Except for the development and application of genetic diagnosis and treatment technology)technology development in the field,technical consulting,technology transfer,Technical Services;Import and export,Technology Import and Export;Information Technology Consulting Services,Business Management Consulting Services(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan.

Union Stem Cell & Gene Engineering Co., Ltd. engages in the development of stem cell therapeutic products. Its business activities include stem cell resource conservation, stem cell clinical transplant, and research and development of monoclonal antibodies treatment and gene chip. The company was founded on February 16, 2001 and is headquartered in Tianjin, China.

NEXEL Co., Ltd. is a company headquartered in Seoul, the South Korea. The firm develops functional human cells from steam cells and therapeutics. It was founded in 2012 by Tae-Won Kang and Chung-Seong Han. Chung-Seong Han has been the CEO since the inception date.\nThe company says this about itself: NEXEL, Co., Ltd. is a bio-company that was incorporated in 2012 with proprietary stem cell technologies. Their philosophy is to ?make a better place? by supporting innovative research around the globe by providing high quality stem cell-derived cell products. NEXEL, Co., Ltd. launched the Cardiosight?-S in 2018 which has since been validated on multiple platforms as a pure and functional population of hiPSC-derived cardiomyocytes. Other product lines include the Hepatosight?-S (iPS-derived hepatocytes) and the Neurosight?-S (iPS-derived neurons).

Hunan Originator Biotechnology Co., Ltd., established on 2021-06-11, Business scope includes biological resources,Stem cell and immune cell storage and biotransformation medical technology services;Biological product,Wholesale of Class I Medical Devices;Medical Research and Experimental Development;Biotechnology Extension Services;research and development,Incubation and Transformation;Hospital Operations and Management;Medical device technology promotion service;Self-operated and agent import and export of various commodities and technologies,Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of;Sub-health intervention technology promotion;Sub-health intervention technology research;Medical laboratory technical service;Class II medical device,Class III Medical Devices,cosmetic,Health products,Sales of biological reagents;Medical Laboratory Technology,Sub-health intervention technology,Research and development of new specialty drugs;Medical laboratory technical consultation;Health Checkup Service;health management;Nutrition and Health Consulting Services;Health Care Services;beauty service;Technology intermediary service;Clinical Laboratory Services;Internet drug information service;Drug storage technology information consultation;medicine,Class III Medical Devices,Healthy food,cosmetic,Health products,Class II medical device,Research and development of a class of medical devices;Mental Rehabilitation Services;Medical Laboratory;Biological product,Production of Class I Medical Devices;Biopharmaceutical Manufacturing;Beauty Specialist;Cosmetic Dermatology;Hospital operation management consulting.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Nanjing Aierpu Zaisheng Medical Technology Co. Ltd. is a company headquartered in Nanjing, China, that develops pluripotent stem cell technology to regenerate myocardial, liver, nerve and other tissues and organs. The firm was founded in 2016 by Jia Xian Wang.

Dongguk University Industry-Academic Cooperation Foundation is for the promotion of tenants and entrepreneurship.

Manufactures and sells pharmaceuticals

Tianjin Heze Stem Cell Technology Co., Ltd., established on 2010-08-23, Business scope includes life science technology development,Technology development and manufacture of stem cell engineering series products,Sales(Does not contain food,medicine,Health products);Industrialization of Stem Cell Series Technical Engineering Products;own property for rent;Research and development of related technologies for skin care products;Hair category,Skin care,Beauty Retouching,Perfume Cosmetics Production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)